[ET Net News Agency, 6 July 2021] China Medical System Holdings Limited (00867) said
New Drug Application of Diazepam Nasal Spray (the product) has been accepted by the
National Medical Products Administration of the People's Republic of China.
The product is an acute treatment of intermittent, stereotypic episodes of frequent
seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct
from a patient's usual seizure pattern in people with epilepsy 6 years of age and older.
The product had been approved by the U.S. Food and Drug Administration. (RC)